MYDA Advisors’s Biohaven BHVN Stock Holding History

MYDA Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$595K	Buy	+40,000	New	+$431K	0.09%	132
2025 Q4	–	Sell	-120,000	Closed	-$1.8M	–	149
2025 Q3	$1.8M	Buy	+120,000	New	+$1.75M	0.39%	68

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MYDA Advisors's BHVN Position: Q2 2026 in Review

MYDA Advisors reduced its Biohaven (BHVN) stake by 6.1% in Q2 2026, selling an estimated $807K and leaving 1,150,000 shares worth $17.1M. The position accounts for 2.55% of the portfolio, ranked #8.

MYDA Advisors first reported a position in BHVN in Q1 2023 and has held it in 12 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

MYDA Advisors held 1,150,000 shares of Biohaven worth $17.1M as of Q2 2026.
MYDA Advisors sold 75,000 Biohaven shares in Q2 2026, an estimated $807K.
Biohaven made up 2.55% of MYDA Advisors's portfolio in Q2 2026, its #8 holding.
MYDA Advisors first reported a position in Biohaven in Q1 2023 and has held it in 12 quarters since.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.